The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.

GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.

The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...

Alzheimer's disease, which affects more than 7million Americans, is caused by the abnormal build-up of proteins in and around ...

GE HealthCare announced today that it entered into an agreement to acquire AI-powered imaging company Icometrix.

GE HealthCare said this morning it has entered into an agreement to acquire icometrix, which provides AI-powered brain ...

A new Johns Hopkins study reveals a non-invasive brain scan, QSM MRI, that can predict dementia risk years before symptoms ...

The physicality of football can't be understated. The full contact display is both the games appeal and its danger. Sometimes ...

Chances are when you've gone for a High Street eye test and the optician offers you an extra scan for an additional £10 to ...

The Meridian Township Police in Lansing, MI, recommended that prosecutors charge Dr. Paul Gregory St. Claire formerly of the ...

Compared to traditional imaging options for Alzheimer’s diagnosis, including PET scans, QSM MRI is “non-invasive and much ...